MwanzoIPCALAB • NSE
add
IPCA Laboratories Ltd
Bei iliyotangulia
₹ 1,223.85
Bei za siku
₹ 1,197.10 - ₹ 1,229.90
Bei za mwaka
₹ 758.40 - ₹ 1,374.60
Thamani ya kampuni katika soko
310.79B INR
Wastani wa hisa zilizouzwa
elfu 705.20
Uwiano wa bei na mapato
56.79
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 20.33B | 34.15% |
Matumizi ya uendeshaji wa biashara | 11.23B | 101.25% |
Mapato halisi | 595.90M | -22.12% |
Kiwango cha faida halisi | 2.93 | -41.98% |
Mapato kwa kila hisa | 7.74 | 131.74% |
EBITDA | 3.44B | 63.80% |
Asilimia ya kodi ya mapato | 98.23% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.55B | -60.70% |
Jumla ya mali | 111.01B | 28.69% |
Jumla ya dhima | 33.74B | 24.46% |
Jumla ya hisa | 77.27B | — |
hisa zilizosalia | 253.57M | — |
Uwiano wa bei na thamani | 4.90 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 5.98% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 595.90M | -22.12% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
Ilianzishwa
19 Okt 1949
Tovuti
Wafanyakazi
16,167
